CAMBRIDGE, Massachusetts, December 5—The Financing and Reimbursement of Cures in the US Consortium (FoCUS) launched the Paying for Cures Toolkit today. The free online resource helps payers, patient advocates, drug … Read More
Downstream Innovation Part I
There is a growing recognition of the importance of augmenting product- focused learning with disease-focused learning, incorporating the value of advances in real-world evidence (RWE). In LEAPS, we aim to … Read More
Tools for Implementation of Precision Financing Solutions Within Medicaid Plans
Implementation of precision financing solutions is a challenge for state Medicaid payers given the complexity of the environment. This white paper provides example templates to support state Medicaid plans, manufacturers, and … Read More
Advancing Healthcare through Innovation and Collaboration
NEWDIGS is an exciting and innovative approach to developing solutions for systemwide impediments to biomedical innovation and patient care. The noncompetitive, collaborative environment encourages novel and fresh ideas and interactions to … Read More
Dr Gigi Hirsch speaks on Milken Institute Future Health Summit
On October 29 Dr Hirsch participated in a panel discussion titled, “Flipping the Script: Designing the System to Deliver for Patients” in Washington, DC. The diverse panel covered the challenges … Read More
NEWDIGS welcomes new team members
Karen Katz, JD Director, FoCUS Project Ms. Katz joins the NEWDIGS team as Director of the FoCUS Project. Prior to joining NEWDIGS, she was Director, Intellectual Property Programs, Suffolk University … Read More
Advancing Healthcare through Innovation and Collaboration
An Interview with Gigi Hirsch, MD for Evidera | PPD publication: The Evidence Forum Dr Gigi Hirsch and Dr Debra Schaumberg, Vice President, Scientific Affairs, Real-World Evidence at Evidera, discuss the … Read More
Payer Perspectives on Financing and Reimbursement of One-time High-cost Durable Treatments
An online 15-question survey was conducted with clinical and financial health plan leaders from US payers between September 2018 and April 2019. The survey was focused on assessing payer perspectives … Read More
Tracking Medicaid Coverage of Durable Cell and Gene Therapies
Durable cell and gene therapies represent a unique challenge to the US healthcare insurer/payer landscape, given the one-time treatment and associated high upfront cost but potentially durable outcomes. This study … Read More
Transforming Real-World Evidence in Biomedical Innovation: Advancing the Design of Collaborative Disease-Focused Learning Ecosystems
The LEAPS methodology begins by answering two structured questions – WHAT evidence to produce, and HOW to produce it, as outlined in this two-part Research Brief series: • Part I: … Read More